IL-33: An alarmin cytokine with crucial roles in innate immunity, inflammation and allergy

Current Opinion in Immunology

Volumn 31, Issue , 2014, Pages 31-37

  Cayrol, Corinne ^a   Girard, Jean Philippe ^b  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

^b UNIVERSITÉ PAUL SABATIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALARMIN; CATHEPSIN G; ELASTASE; HISTONE H2A; HISTONE H2B; INTERLEUKIN 13; INTERLEUKIN 33; RETINOID RELATED ORPHAN RECEPTOR ALPHA; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-33, MOUSE;

ADAPTIVE IMMUNITY; ALLERGY; ARTICLE; ATOPIC DERMATITIS; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION REGULATION; HOMEOSTASIS; HUMAN; IN VIVO STUDY; INFLAMMATION; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LYMPHOID CELL; MACROPHAGE; NONHUMAN; OSMOTIC STRESS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; RETICULUM CELL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; ANIMAL; ASTHMA; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MOUSE; PATHOLOGY;

ANIMALS; ASTHMA; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERLEUKINS; MICE; MICE, KNOCKOUT; SIGNAL TRANSDUCTION;

EID: 84920950343     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2014.09.004     Document Type: Review

References (49)

1. Baekkevold ES, Roussigne M, Yamanaka T, Johansen FE, Jahnsen FL, Amalric F, Brandtzaeg P, Erard M, Haraldsen G, Girard JP: Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules. Am J Pathol 2003, 163:69-79.
2. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, Aguilar L, Bouche G, Girard JP: IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 2007, 104:282-287.
3. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, Zurawski G, MoshrefiM, Qin J, Li X et al.: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
4. Liu X, Hammel M, He Y, Tainer JA, Jeng US, Zhang L, Wang S, Wang X: Structural insights into the interaction of IL-33 with its receptors. Proc Natl Acad Sci U S A 2013, 110:14918-14923.
5. Liew FY, Pitman NI, McInnes IB: Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol 2010, 10:103-110.
6. Garlanda C, Dinarello CA, Mantovani A: The interleukin-1 family: back to the future. Immunity 2013, 39:1003-1018.
7. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S: Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature 2010, 463:540-544.
8. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R et al.: Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 2010, 464:1367-1370.
9. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM: Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci U S A 2010, 107:11489-11494.
10. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H: Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011, 12:1055-1062.
11. Walker JA, McKenzie AN: Development and function of group 2 innate lymphoid cells. Curr Opin Immunol 2013, 25:148-155.
12. Kim BS, Wojno ED, Artis D: Innate lymphoid cells and allergic inflammation. Curr Opin Immunol 2013, 25:738-744.
13. Nussbaum JC, Van Dyken SJ, von Moltke J, Cheng LE, Mohapatra A, Molofsky AB, Thornton EE, Krummel MF, Chawla A, Liang HE et al.: Type 2 innate lymphoid cells control eosinophil homeostasis. Nature 2013, 502:245-248.
14. Hung LY, Lewkowich IP, Dawson LA, Downey J, Yang Y, Smith DE, Herbert DR: IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A 2013, 110:282-287.
15. Spooner CJ, Lesch J, Yan D, Khan AA, Abbas A, Ramirez-Carrozzi V, Zhou M, Soriano R, Eastham-Anderson J, Diehl L et al.: Specification of type 2 innate lymphocytes by the transcriptional determinant Gfi1. Nat Immunol 2013, 14:1229-1236.
16. Yasuda K, Muto T, Kawagoe T, Matsumoto M, Sasaki Y, Matsushita K, Taki Y, Futatsugi-Yumikura S, Tsutsui H, Ishii KJ et al.: Contribution of IL-33-activated type II innate lymphoid cells to pulmonary eosinophilia in intestinal nematodeinfected mice. Proc Natl Acad Sci U S A 2012, 109:3451-3456.
17. Van Dyken SJ, Mohapatra A, Nussbaum JC, Molofsky AB, Thornton EE, Ziegler SF, McKenzie AN, Krummel MF, Liang HE, Locksley RM: Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and gammadelta T cells. Immunity 2014, 40:414-424.
18. Monticelli LA, Sonnenberg GF, Abt MC, Alenghat T, Ziegler CG, Doering TA, Angelosanto JM, Laidlaw BJ, Yang CY, Sathaliyawala T et al.: Innate lymphoid cells promote lungtissue homeostasis after infection with influenza virus. Nat Immunol 2011, 12:1045-1054.
19. Chang YJ, Kim HY, Albacker LA, Baumgarth N, McKenzie AN, Smith DE, DekruyffRH, Umetsu DT: Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol 2011, 12:631-638.
20. Byers DE, Alexander-Brett J, Patel AC, Agapov E, Dang-Vu G, Jin X, Wu K, You Y, Alevy Y, Girard JP et al.: Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease. J Clin Invest 2013, 123:3967-3982.
21. Bonilla WV, Frohlich A, Senn K, Kallert S, Fernandez M, Johnson S, Kreutzfeldt M, Hegazy AN, Schrick C, Fallon PG et al.: The alarmin interleukin-33 drives protective antiviral CD8 T cell responses. Science 2012, 335:984-989.
22. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, Abe T, Kiyonari H, Matsumoto K et al.: IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 2010, 107:18581-18586.
23. Louten J, Rankin AL, Li Y, Murphy EE, Beaumont M, Moon C, Bourne P, McClanahan TK, Pflanz S, de Waal Malefyt R: Endogenous IL-33 enhances Th2 cytokine production and Tcell responses during allergic airway inflammation. Int Immunol 2011, 23:307-315.
24. Bartemes KR, Iijima K, Kobayashi T, Kephart GM, McKenzie AN, Kita H: IL-33-responsive lineage-CD25+CD44hi lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J Immunol 2012, 188:1503-1513.
25. Barlow JL, Peel S, Fox J, Panova V, Hardman CS, Camelo A, Bucks C, Wu X, Kane CM, Neill DR et al.: IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J Allergy Clin Immunol 2013, 132:933-941.
26. Kamijo S, Takeda H, Tokura T, Suzuki M, Inui K, Hara M, Matsuda H, Matsuda A, Oboki K, Ohno T et al.: IL-33-mediated innate response and adaptive immune cells contribute to maximum responses of protease allergen-induced allergic airway inflammation. J Immunol 2013, 190:4489-4499.
27. Halim TY, Steer CA, Matha L, Gold MJ, Martinez-Gonzalez I, McNagny KM, McKenzie AN, Takei F: Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity 2014, 40:425-435.
28. Hara K, Iijima K, Elias MK, Seno S, Tojima I, Kobayashi T, Kephart GM, Kurabayashi M, Kita H: Airway uric acid is a sensor of inhaled protease allergens and initiates type 2 immune responses in respiratory mucosa. J Immunol 2014, 192:4032-4042.
29. Haenuki Y, Matsushita K, Futatsugi-Yumikura S, Ishii KJ, Kawagoe T, Imoto Y, Fujieda S, Yasuda M, Hisa Y, Akira S et al.: A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol 2012, 130 184-194 e111.
30. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN et al.: A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 2013, 210:2939-2950.
31. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, Jonsdottir GM, Thorleifsson G, Helgadottir H, Steinthorsdottir V, Stefansson H et al.: Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 2009, 41:342-347.
32. Moffatt MF, Gut IG, Demenais F, Strachan DP, Bouzigon E, Heath S, von Mutius E, Farrall M, Lathrop M, Cookson WO: A large-scale, consortium-based genomewide association study of asthma. N Engl J Med 2010, 363:1211-1221.
33. Torgerson DG, Ampleford EJ, Chiu GY, Gauderman WJ, Gignoux CR, Graves PE, Himes BE, Levin AM, Mathias RA, Hancock DB et al.: Meta-analysis of genome-wide association studies of asthma in ethnically diverse North American populations. Nat Genet 2011, 43:887-892.
34. Ramasamy A, Kuokkanen M, Vedantam S, Gajdos ZK, Couto Alves A, Lyon HN, Ferreira MA, Strachan DP, Zhao JH, Abramson MJ et al.: Genome-wide association studies of asthma in population-based cohorts confirm known and suggested loci and identify an additional association near HLA. PLoS ONE 2012, 7:e44008.
35. Bonnelykke K, Sleiman P, Nielsen K, Kreiner-Moller E, Mercader JM, Belgrave D, den Dekker HT, Husby A, Sevelsted A, Faura-Tellez G et al.: A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations. Nat Genet 2014, 46:51-55.
36. Moussion C, Ortega N, Girard JP: The IL-1-like cytokine IL-33 is constitutively expressed in the nucleus of endothelial cells and epithelial cells in vivo: a novel 'alarmin'? PLoS ONE 2008, 3:e3331.
37. Pichery M, Mirey E, Mercier P, Lefrancais E, Dujardin A, Ortega N, Girard JP: Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel IL-33-LacZ gene trap reporter strain. J Immunol 2012, 188:3488-3495.
38. Roussel L, Erard M, Cayrol C, Girard JP: Molecular mimicry between IL-33 and KSHV for attachment to chromatin through the H2A-H2B acidic pocket. EMBO Rep 2008, 9:1006-1012.
39. Bessa J, Meyer CA, de Vera Mudry MC, Schlicht S, Smith SH, Iglesias A, Cote-Sierra J: Altered subcellular localization of IL-33 leads to non-resolving lethal inflammation. J Autoimmun 2014 http://dx.doi.org/10.1016/j.jaut.2014.02.012.
40. Hardman CS, Panova V, McKenzie AN: IL-33 citrine reporter mice reveal the temporal and spatial expression of IL-33 during allergic lung inflammation. Eur J Immunol 2013, 43:488-498.
41. Prefontaine D, Nadigel J, Chouiali F, Audusseau S, Semlali A, Chakir J, Martin JG, Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol 2010, 125:752-754.
42. Arshad MI, Piquet-Pellorce C, L'Helgoualc'h A, Rauch M, Patrat-Delon S, Ezan F, Lucas-Clerc C, Nabti S, Lehuen A, Cubero FJ et al.: TRAIL but not FasL and TNFalpha, regulates IL-33 expression in murine hepatocytes during acute hepatitis. Hepatology 2012, 56:2353-2362.
43. Tjota MY, Williams JW, Lu T, Clay BS, Byrd T, Hrusch CL, Decker DC, de Araujo CA, Bryce PJ, Sperling AI: IL-33-dependent induction of allergic lung inflammation by FcgammaRIII signaling. J Clin Invest 2013, 123:2287-2297.
44. Nakanishi W, Yamaguchi S, Matsuda A, Suzukawa M, Shibui A, Nambu A, Kondo K, Suto H, Saito H, Matsumoto K et al.: IL-33, but Not IL-25, is crucial for the development of house dust mite antigen-induced allergic rhinitis. PLoS ONE 2013, 8:e78099.
45. Cayrol C, Girard JP: The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A 2009, 106:9021-9026.
46. Luthi AU, Cullen SP, McNeela EA, Duriez PJ, Afonina IS, Sheridan C, Brumatti G, Taylor RC, Kersse K, Vandenabeele P et al.: Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity 2009, 31:84-98.
47. Kouzaki H, Iijima K, Kobayashi T, O'Grady SM, Kita H: The danger signal, extracellular ATP, is a sensor for an airborne allergen and triggers IL-33 release and innate Th2-type responses. J Immunol 2011, 186:4375-4387.
48. Snelgrove RJ, Gregory LG, Peiro T, Akthar S, Campbell GA, Walker SA, Lloyd CM: Alternaria-derived serine protease activity drives IL-33 mediated asthma exacerbations. J Allergy Clin Immunol 2014, 134 583-592.e6.
49. Lefrancais E, Roga S, Gautier V, Gonzalez-de-Peredo A, Monsarrat B, Girard JP, Cayrol C: IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A 2012, 109:1673-1678.